Safety, pharmacokinetics and pharmacodynamics of an original glycoprotein IIb/IIIa inhibitor in healthy volunteers: results of the clinical trial

Aim. To study the tolerability, safety, pharmacokinetics (PK) and pharmacodynamics of single intravenous infusions of Angipur in healthy male volunteers.Material and methods. The Phase I trial included 20 healthy male volunteers (mean age, 30,8±7,7 years; mean body weight, 77,4±12,1 kg). Angipur (0,...

Full description

Saved in:
Bibliographic Details
Main Authors: S. B. Fitilev, Yu. F. Glukhov, S. V. Lukyanov, A. V. Vozzhaev, I. I. Shkrebniova, V. I. Kazey, I. B. Bondareva
Format: Article
Language:Russian
Published: «SILICEA-POLIGRAF» LLC 2022-03-01
Series:Кардиоваскулярная терапия и профилактика
Subjects:
Online Access:https://cardiovascular.elpub.ru/jour/article/view/3033
Tags: Add Tag
No Tags, Be the first to tag this record!